Large scale multi-omics can empower drug discovery and development at every pipeline stage

We talk, through several examples, how large biobank discoveries have shown novel disease insights that translate into advancement of drug discovery and development

The audience will gain:

• Appreciation on the role of large scale multi-omics plays on drug discovery Insights from combining rare variant genetic data and plasma proteomics in biobank
• Rare variant analysis combined with insights from plasma proteomes can impact drug development in rare and common diseases.